Orthopaedic Considerations in the Management of Skeletal Sarcoidosis

被引：2

作者：

Crawford, Brooke ^{[1
,2
,4
]}

Badlissi, Fadi ^{[3
]}

Lozano Calderon, Santiago A. ^{[1
]}

机构：

[1] Massachusetts Gen Hosp, Dept Orthopaed Surg, Musculoskeletal Oncol Div, Boston, MA 02114 USA

[2] Beth Israel Deaconess Med Ctr, Dept Orthopaed Surg, Boston, MA 02215 USA

[3] Beth Israel Deaconess Med Ctr, Dept Rheumatol, Boston, MA 02215 USA

[4] Boston Childrens Hosp, Dept Orthopaed Surg, Boston, MA 02115 USA

来源：

JOURNAL OF THE AMERICAN ACADEMY OF ORTHOPAEDIC SURGEONS | 2018年 / 26卷 / 06期

关键词：

NECROSIS-FACTOR-ALPHA; OF-THE-LITERATURE; CLINICAL CHARACTERISTICS; OSSEOUS SARCOIDOSIS; INFLIXIMAB THERAPY; MUSCULOSKELETAL; INVOLVEMENT; BONE; EPIDEMIOLOGY; ARTHROPATHY;

D O I：

10.5435/JAAOS-D-16-00252

中图分类号：

R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学（修复外科学）];

学科分类号：

摘要：

Advanced imaging has demonstrated that musculoskeletal manifestations of systemic sarcoidosis are more common than previously thought. A definitive strategy for the management of osseous sarcoidosis has not been defined. Some lesions resolve spontaneously, and no systemic medication for sarcoidosis consistently resolves lesions. The orthopaedic surgeon treating patients with musculoskeletal sarcoidosis must make an appropriate diagnosis of bony lesions, seek multidisciplinary input from specialists in pulmonology and rheumatology regarding systemic treatment, and decide when surgery is necessary to prevent dysfunction.

引用

页码：197 / 203

页数：7

共 43 条

[1]

Abril Andy, 2004, Current Opinion in Rheumatology, V16, P51, DOI 10.1097/00002281-200401000-00010

[2] Sarcoid sacroiliitis: successful treatment with infliximab [J].

Agrawal, S. ;

Bhagat, S. ;

Dasgupta, B. .

ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (02) :283-283

[3]

Anakwenze OA., 2010, Orthopedics, V33, P308

[4] Multimodality evaluation of musculoskeletal sarcoidosis: Imaging findings and literature review [J].

Aptel, S. ;

Lecocq-Teixeira, S. ;

Olivier, P. ;

Regent, D. ;

Teixeira, P. Gondim ;

Blum, A. .

DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2016, 97 (01) :5-18

[5] Musculoskeletal and other extrapulmonary disorders in sarcoidosis [J].

Awada, H ;

Abi-Karam, G ;

Fayad, F .

BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY, 2003, 17 (06) :971-987

[6]

BASCOM R, 1986, ADV INTERNAL MED, V31, P213

[7] Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement [J].

Baughman, Robert P. ;

Drent, Marjolein ;

Kavuru, Mani ;

Judson, Marc A. ;

Costabel, Ulrich ;

du Bois, Roland ;

Albera, Carlo ;

Brutsche, Martin ;

Davis, Gerald ;

Donohue, James F. ;

Mueller-Quernheim, Joachim ;

Schlenker-Herceg, Rozsa ;

Flavin, Susan ;

Lo, Kim Hung ;

Oemar, Barry ;

Barnathan, Elliot S. .

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (07) :795-802

[8] Steroid-sparing alternative treatments for sarcoidosis [J].

Baughman, RP ;

Lower, EE .

CLINICS IN CHEST MEDICINE, 1997, 18 (04) :853-+

[9] Dual role of anti-TNF therapy: Enhancement of TCR-mediated T cell activation in peripheral blood and inhibition of inflammation in target tissues [J].

Bose, Francesca ;

Raeli, Lorenzo ;

Garutti, Cecilia ;

Frigerio, Elena ;

Cozzi, Alessandra ;

Crimi, Marco ;

Caprioli, Flavio ;

Scavelli, Rossana ;

Altomare, Gianfranco ;

Geginat, Jens ;

Abrignani, Sergio ;

Reali, Eva .

CLINICAL IMMUNOLOGY, 2011, 139 (02) :164-176

[10]

Braunwald E, 2003, HARRISONS MANUAL MED

← 1 2 3 4 5 →